164 related articles for article (PubMed ID: 36504325)
1. Chromium (VI)-induced ALDH1A1/EGF axis promotes lung cancer progression.
Ge X; Li M; Song GX; Zhang Z; Yin J; Ge Z; Shi Z; Liu LZ; Jiang BH; Qian X; Shen H
Clin Transl Med; 2022 Dec; 12(12):e1136. PubMed ID: 36504325
[TBL] [Abstract][Full Text] [Related]
2. Chromium (VI) promotes lung cancer initiation by activating EGF/ALDH1A1 signalling.
Metropulos AE; Becker JH; Principe DR
Clin Transl Discov; 2022 Dec; 2(4):. PubMed ID: 37396570
[TBL] [Abstract][Full Text] [Related]
3. ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid-Derived Suppressor Cells to Promote Breast Cancer Progression.
Liu C; Qiang J; Deng Q; Xia J; Deng L; Zhou L; Wang D; He X; Liu Y; Zhao B; Lv J; Yu Z; Lei QY; Shao ZM; Zhang XY; Zhang L; Liu S
Cancer Res; 2021 Dec; 81(23):5919-5934. PubMed ID: 34580061
[TBL] [Abstract][Full Text] [Related]
4. Chronic Hexavalent Chromium Exposure Induces Cancer Stem Cell-Like Property and Tumorigenesis by Increasing c-Myc Expression.
Wang Z; Lin HP; Li Y; Tao H; Yang P; Xie J; Maddy D; Kondo K; Yang C
Toxicol Sci; 2019 Dec; 172(2):252-264. PubMed ID: 31504995
[TBL] [Abstract][Full Text] [Related]
5. Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome.
Li X; Wan L; Geng J; Wu CL; Bai X
J Thorac Oncol; 2012 Aug; 7(8):1235-45. PubMed ID: 22617249
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer.
Alamgeer M; Ganju V; Szczepny A; Russell PA; Prodanovic Z; Kumar B; Wainer Z; Brown T; Schneider-Kolsky M; Conron M; Wright G; Watkins DN
Thorax; 2013 Dec; 68(12):1095-104. PubMed ID: 23878161
[TBL] [Abstract][Full Text] [Related]
7. All-trans retinoic acid reduces cancer stem cell-like cell-mediated resistance to gefitinib in NSCLC adenocarcinoma cells.
Yao W; Wang L; Huang H; Li X; Wang P; Mi K; Cheng J; Liu H; Gu C; Huang L; Huang J
BMC Cancer; 2020 Apr; 20(1):315. PubMed ID: 32293355
[TBL] [Abstract][Full Text] [Related]
8. The SOX9-Aldehyde Dehydrogenase Axis Determines Resistance to Chemotherapy in Non-Small-Cell Lung Cancer.
Voronkova MA; Rojanasakul LW; Kiratipaiboon C; Rojanasakul Y
Mol Cell Biol; 2020 Jan; 40(2):. PubMed ID: 31658996
[TBL] [Abstract][Full Text] [Related]
9. Chronic Hexavalent Chromium Exposure Upregulates the RNA Methyltransferase METTL3 Expression to Promote Cell Transformation, Cancer Stem Cell-Like Property, and Tumorigenesis.
Wang Z; Uddin MB; Xie J; Tao H; Zeidler-Erdely PC; Kondo K; Yang C
Toxicol Sci; 2022 Apr; 187(1):51-61. PubMed ID: 35201342
[TBL] [Abstract][Full Text] [Related]
10. Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling.
Sullivan JP; Spinola M; Dodge M; Raso MG; Behrens C; Gao B; Schuster K; Shao C; Larsen JE; Sullivan LA; Honorio S; Xie Y; Scaglioni PP; DiMaio JM; Gazdar AF; Shay JW; Wistuba II; Minna JD
Cancer Res; 2010 Dec; 70(23):9937-48. PubMed ID: 21118965
[TBL] [Abstract][Full Text] [Related]
11. ALDH1A1 maintains the cancer stem-like cells properties of esophageal squamous cell carcinoma by activating the AKT signal pathway and interacting with β-catenin.
Wang W; He S; Zhang R; Peng J; Guo D; Zhang J; Xiang B; Li L
Biomed Pharmacother; 2020 May; 125():109940. PubMed ID: 32044720
[TBL] [Abstract][Full Text] [Related]
12. ALDH1A1 defines invasive cancer stem-like cells and predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Yang L; Ren Y; Yu X; Qian F; Bian BS; Xiao HL; Wang WG; Xu SL; Yang J; Cui W; Liu Q; Wang Z; Guo W; Xiong G; Yang K; Qian C; Zhang X; Zhang P; Cui YH; Bian XW
Mod Pathol; 2014 May; 27(5):775-83. PubMed ID: 24201124
[TBL] [Abstract][Full Text] [Related]
13. Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer.
Kahlert C; Bergmann F; Beck J; Welsch T; Mogler C; Herpel E; Dutta S; Niemietz T; Koch M; Weitz J
BMC Cancer; 2011 Jun; 11():275. PubMed ID: 21708005
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of ALDH1A1-positive cancer stem cells in patients with locally advanced, metastasized head and neck squamous cell carcinoma.
Qian X; Wagner S; Ma C; Coordes A; Gekeler J; Klussmann JP; Hummel M; Kaufmann AM; Albers AE
J Cancer Res Clin Oncol; 2014 Jul; 140(7):1151-8. PubMed ID: 24770634
[TBL] [Abstract][Full Text] [Related]
15. Serum ALDH1A1 is a tumor marker for the diagnosis of non-small cell lung cancer.
Cao YT; Li JH; Wang YT; Fu YW; Xu J
Tumori; 2014; 100(2):214-8. PubMed ID: 24852868
[TBL] [Abstract][Full Text] [Related]
16. Associations of carboxypeptidase 4 with ALDH1A1 expression and their prognostic value in esophageal squamous cell carcinoma.
Sun L; Cao J; Guo C; Burnett J; Yang Z; Ran Y; Sun D
Dis Esophagus; 2017 Jun; 30(6):1-5. PubMed ID: 28475748
[TBL] [Abstract][Full Text] [Related]
17. Targeting S100A9-ALDH1A1-Retinoic Acid Signaling to Suppress Brain Relapse in EGFR-Mutant Lung Cancer.
Biswas AK; Han S; Tai Y; Ma W; Coker C; Quinn SA; Shakri AR; Zhong TJ; Scholze H; Lagos GG; Mela A; Manova-Todorova K; de Stanchina E; Ferrando AA; Mendelsohn C; Canoll P; Yu HA; Paik PK; Saqi A; Shu CA; Kris MG; Massague J; Acharyya S
Cancer Discov; 2022 Apr; 12(4):1002-1021. PubMed ID: 35078784
[TBL] [Abstract][Full Text] [Related]
18. Aldehyde dehydrogenase 1A1 confers erlotinib resistance via facilitating the reactive oxygen species-reactive carbonyl species metabolic pathway in lung adenocarcinomas.
Lei HM; Zhang KR; Wang CH; Wang Y; Zhuang GL; Lu LM; Zhang J; Shen Y; Chen HZ; Zhu L
Theranostics; 2019; 9(24):7122-7139. PubMed ID: 31695757
[No Abstract] [Full Text] [Related]
19. Downregulation of hedgehog-interacting protein (HHIP) contributes to hexavalent chromium-induced malignant transformation of human bronchial epithelial cells.
Li P; Zhang X; Murphy AJ; Costa M; Zhao X; Sun H
Carcinogenesis; 2021 Feb; 42(1):136-147. PubMed ID: 32710611
[TBL] [Abstract][Full Text] [Related]
20. ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription.
Gorodetska I; Offermann A; Püschel J; Lukiyanchuk V; Gaete D; Kurzyukova A; Freytag V; Haider MT; Fjeldbo CS; Di Gaetano S; Schwarz FM; Patil S; Borkowetz A; Erb HHH; Baniahmad A; Mircetic J; Lyng H; Löck S; Linge A; Lange T; Knopf F; Wielockx B; Krause M; Perner S; Dubrovska A
Theranostics; 2024; 14(2):714-737. PubMed ID: 38169509
[No Abstract] [Full Text] [Related]
[Next] [New Search]
